| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PF-543 | CTRPv2 | pan-cancer | AAC | 0.0093 | 0.8 |
| mRNA | ML083 | CTRPv2 | pan-cancer | AAC | -0.0095 | 0.8 |
| mRNA | KU 0060648 | CTRPv2 | pan-cancer | AAC | 0.0086 | 0.8 |
| mRNA | ML203 | CTRPv2 | pan-cancer | AAC | -0.0091 | 0.8 |
| mRNA | BRD-K03536150 | CTRPv2 | pan-cancer | AAC | 0.0088 | 0.8 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.0073 | 0.8 |
| mRNA | AT13387 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | N9-isopropylolomoucine | CTRPv2 | pan-cancer | AAC | 0.0084 | 0.8 |
| mRNA | Mdivi-1 | CTRPv2 | pan-cancer | AAC | -0.0083 | 0.8 |
| mRNA | AZD-7545 | CTRPv2 | pan-cancer | AAC | 0.0082 | 0.8 |